Company intelligence / Profile preview

Atentiv

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Developed non-pharmaceutical neurofeedback-based digital therapeutics using EEG to train attention and impulse control in ADHD patients; assets acquired by Thynk Inc. in early 2023.

Therapeutic areas: Psychiatry
Modalities: Digital therapeutic
Industry: Digital Health Medical Devices

Partnerships

RWJBarnabas Health System (Children's Specialized Hospital)

Beyond the preview

Go deeper on Atentiv.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atentiv.

Explore the full profile